SCHEMBL30202682

SCHEMBL30202682

CCOC(=O)c1ccc(C)c(NC(=O)c2cnc(Cl)nc2N(C)N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ATF1 P18846 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ DYRK1A Q13627 1/20 0.42
▸ DYRK1B Q9Y463 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ WDR5 P61964 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24951831 1.00 ALDH1A1 (0.46) ALDH1A1KDM4EATF1NFKB1KMT2A
SCHEMBL24951146 0.92 WDR5 (0.47) ALDH1A1KDM4EATF1NFKB1KMT2A
SCHEMBL30202783 0.92 WDR5 (0.47) ALDH1A1KDM4EATF1NFKB1KMT2A
SCHEMBL24951472 0.88 NFKB1 (0.46) ALDH1A1KDM4EATF1NFKB1RAB9A
SCHEMBL24951630 0.87 ALDH1A1 (0.50) ALDH1A1KDM4EATF1NFKB1KMT2A
SCHEMBL30202869 0.87 ALDH1A1 (0.50) ALDH1A1KDM4EATF1NFKB1KMT2A
SCHEMBL24952254 0.83 RAB9A (0.47) ALDH1A1KDM4ENFKB1KMT2AMEN1
SCHEMBL22145716 0.78 NPC1 (0.50) ALDH1A1KDM4ENFKB1KMT2ARAB9A
SCHEMBL24951126 0.77 NFKB1 (0.50) ALDH1A1KDM4EATF1NFKB1KMT2A
SCHEMBL30202837 0.77 NFKB1 (0.50) ALDH1A1KDM4EATF1NFKB1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4376845-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS Actelion Pharmaceuticals Ltd (CH) 2024-06-05 — — EP disclosed
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback